11:36 AM EST - BriaCell Therapeutics Corp. : Is presenting positive data from its preclinical Bria-OTS+ platform at the 2026 American Association for Cancer Research (AACR) Annual Meeting taking place at the San Diego Convention Center in San Diego until Wednesday. BriaCell Therapeutics Corp.
shares T.BCT are trading down $0.07 at $5.42.
